282 Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease.

281 Genetic and functional insights into the fractal structure of the heart.

280 In vivo high-loading peptide nanoparticle administration prevented thrombosis and myocardial injury without causing bleeding in mice.

279 Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

278 Blocking the death checkpoint protein TRAIL improves cardiac function after myocardial infarction in monkeys, pigs, and rats.

277 An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs.

276 Elevated plasma β-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy.

275 Targeted anti–IL-1β platelet microparticles for cardiac detoxing and repair.

274 Cardiac stem cell therapy in mouse models of ischaemia–reperfusion injury demonstrates that improvement in heart function is linked to an immune response characterized by the induction of CCR2+ and CX3CR1+ macrophages.

273 Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Free Images for Presentation: sunipix SUNIPIX